Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Fresenius Kabi terminates $4.3-billion merger agreement with Akorn

firstwordpharmaApril 23, 2018

Tag: Fresenius Kabi , Akorn

PharmaSources Customer Service